{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:22:33Z","timestamp":1774462953389,"version":"3.50.1"},"reference-count":51,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,1,31]]},"DOI":"10.1536\/ihj.19-270","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T22:05:00Z","timestamp":1579212300000},"page":"29-38","source":"Crossref","is-referenced-by-count":5,"title":["Elevated Plasma Adiponectin Levels Are Associated with Abnormal Corrected QT Interval in Patients with Stable Angina"],"prefix":"10.1536","volume":"61","author":[{"given":"Cheng-Ching","family":"Wu","sequence":"first","affiliation":[{"name":"Division of Cardiology, E-Da Hospital"},{"name":"The School of Chinese Medicine for Post Baccalaureate, College of Medicine, I-Shou University"},{"name":"Division of Cardiology, E-Da Cancer Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Sung","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, E-Da Hospital"},{"name":"School of Medicine, I-Shou University"},{"name":"Division of Hematology and Oncology, Department of Internal Medicine, E-Da Cancer Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chang","family":"Hsu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, E-Da Hospital"},{"name":"Division of Gastroenterology and Hepatology, E-Da Dachang Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Ping","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, E-Da Hospital"},{"name":"School of Medicine, I-Shou University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Ting","family":"Tsai","sequence":"additional","affiliation":[{"name":"School of Medicine, I-Shou University"},{"name":"Department of Emergency, E-Da Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Chuan","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Medicine, I-Shou University"},{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, E-Da Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jer-Yiing","family":"Houng","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Institute of Biotechnology and Chemical Engineering, I-Shou University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Chang","family":"Chang","sequence":"additional","affiliation":[{"name":"School of Medicine, I-Shou University"},{"name":"Department of Obstetrics & Gynecology, E-Da Hospital"},{"name":"Department of Obstetrics & Gynecology, E-Da Dachang Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Mei","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Cardiology, E-Da Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yau-Jiunn","family":"Lee","sequence":"additional","affiliation":[{"name":"Lee's Endocrinology Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Chin","family":"Hung","sequence":"additional","affiliation":[{"name":"Division of Cardiology, E-Da Hospital"},{"name":"The School of Chinese Medicine for Post Baccalaureate, College of Medicine, I-Shou University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(99)02107-8","volume":"354","year":"1999","unstructured":"1. Viskin S. Long QT syndromes and torsade de pointes. Lancet 1999; 354: 1625-33.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Morita H, Wu J, Zipes DP. The QT syndromes: long and short. Lancet 2008; 372: 750-63.","DOI":"10.1016\/S0140-6736(08)61307-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kim E, Joo S, Kim J, <i>et al<\/i>. Association between C-reactive protein and QTc interval in middle-aged men and women. Eur J Epidemiol 2006; 21: 653-9.","DOI":"10.1007\/s10654-006-9034-9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kazumi T, Kawaguchi A, Hirano T, Yoshino G. C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metab Clin Exp 2003; 52: 1113-6.","DOI":"10.1016\/S0026-0495(03)00184-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Greensmith DJ, Nirmalan M. The effects of tumor necrosis factor-alpha on systolic and diastolic function in rat ventricular myocytes. Physiol Rep 2013; 1: e00093.","DOI":"10.1002\/phy2.93"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Stengl M, Bartak F, Sykora R, <i>et al<\/i>. Reduced L-type calcium current in ventricular myocytes from pigs with hyperdynamic septic shock. Crit Care Med 2010; 38: 579-87.","DOI":"10.1097\/CCM.0b013e3181cb0f61"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Petkova-Kirova PS, Gursoy E, Mehdi H, McTiernan CF, London B, Salama G. Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha. Am J Physiol Heart Circ Physiol 2006; 290: H2098-107.","DOI":"10.1152\/ajpheart.00097.2005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fern\u00e1ndez-Velasco M, Ruiz-Hurtado G, Hurtado O, Moro MA, Delgado C. TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation. Am J Physiol Heart Circ Physiol 2007; 293: H238-45.","DOI":"10.1152\/ajpheart.01122.2006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Duncan DJ, Yang Z, Hopkins PM, Steele DS, Harrison SM. TNF-a and IL-1b increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes. Cell Calcium 2010; 47: 378-6.","DOI":"10.1016\/j.ceca.2010.02.002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol 2012; 60: 2263-70.","DOI":"10.1016\/j.jacc.2012.04.063"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hijazi Z, Oldgren J, Siegbahn A, Granger CB, Wallentin L. Biomarkers in atrial fibrillation: a clinical review. Eur Heart J 2013; 34: 1475-80.","DOI":"10.1093\/eurheartj\/eht024"},{"key":"12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","volume":"100","year":"1999","unstructured":"12. Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999; 100: 793-8.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Stuart SD, De Jesus NM, Lindsey ML, Ripplinger CM. The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction. J Mol Cell Cardiol 2016; 91: 114-22.","DOI":"10.1016\/j.yjmcc.2015.12.024"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Corrado E, Novo S. Role of inflammation and infection in vascular disease. Acta Chir Belg 2005; 105: 567-79.","DOI":"10.1080\/00015458.2005.11679782"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lazzerini PE, Laghi-Pasini F, Bertolozzi I, <i>et al<\/i>. Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes. Heart 2017; 103: 1821-9.","DOI":"10.1136\/heartjnl-2016-311079"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lindberg S, Pedersen SH, M\u00f8gelvang R, <i>et al<\/i>. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol 2012; 109: 492-6.","DOI":"10.1016\/j.amjcard.2011.09.041"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Karas MG, Benkeser D, Arnold AM, <i>et al<\/i>. Relations of plasma total and high-molecular-weight adiponectin to new-onset heart failure in adults \u226565 years of age (from the Cardiovascular Health study). Am J Cardiol 2014; 113: 328-34.","DOI":"10.1016\/j.amjcard.2013.09.027"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Macheret F, Bartz TM, Djousse L, <i>et al<\/i>. Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults. Heart 2015; 101: 1368-74.","DOI":"10.1136\/heartjnl-2014-307015"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lee Y, Kim BK, Lim YH, Kim MK, Choi BY, Shin J. The relationship between adiponectin and left ventricular mass index varies with the risk of left ventricular hypertrophy. PLoS One 2013; 8: e70246.","DOI":"10.1371\/journal.pone.0070246"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Unno K, Shibata R, Izawa H, <i>et al<\/i>. Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy. Heart 2010; 96: 357-61.","DOI":"10.1136\/hrt.2009.172320"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35: S64-71.","DOI":"10.2337\/dc12-s064"},{"key":"22","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","unstructured":"22. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.","journal-title":"JAMA The Journal of the American Medical Association","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kong X, Ma Y, Chen J, <i>et al<\/i>. Chinese eGFR investigation collaboration. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating glomerular filtration rate in the Chinese population. Nephrol Dial Transplant 2013; 28: 641-51.","DOI":"10.1093\/ndt\/gfs491"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Levey AS, de Jong PE, Coresh J, <i>et al<\/i>. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 2011; 80: 17-28.","DOI":"10.1038\/ki.2010.483"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hanna EB, Chen AY, Roe MT, Wiviott SD, Fox CS, Saucedo JF. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention. JACC Cardiovasc Interv 2011; 4: 1002-8.","DOI":"10.1016\/j.jcin.2011.05.022"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606.","DOI":"10.1016\/S0002-9149(83)80105-2"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Wang CP, Hsu HL, Hung WC, <i>et al<\/i>. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol 2009; 70: 876-82.","DOI":"10.1111\/j.1365-2265.2008.03411.x"},{"key":"28","unstructured":"28. Rautaharju PM, Surawicz B, Gettes LS, <i>et al<\/i>. AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009; 53: 982-91."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Naksuk N, Hu T, Krittanawong C, <i>et al<\/i>. Association of serum magnesium on mortality in patients admitted to the intensive cardiac care unit. Am J Med 2017; 130: 229-e5.","DOI":"10.1016\/j.amjmed.2016.08.033"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Salvi V, Karnad DR, Panicker GK, <i>et al<\/i>. Comparison of 5 methods of QT interval measurements on electrocardiograms from a thorough QT\/QTc study: effect on assay sensitivity and categorical outliers. J Electrocardiol 2011; 44: 96-104.","DOI":"10.1016\/j.jelectrocard.2010.11.010"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Malik M, Hnatkova K, Batchvarov V, Gang Y, Smetana P, Camm AJ. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation. Pacing Clin Electrophysiol 2004; 27: 1659-69.","DOI":"10.1111\/j.1540-8159.2004.00701.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Straus SM, Kors JA, De Bruin ML, <i>et al<\/i>. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006; 47: 362-7.","DOI":"10.1016\/j.jacc.2005.08.067"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Hui X, Lam KS, Vanhoutte PM, Xu A. Adiponectin and cardiovascular health: an update. Br J Pharmacol 2012; 165: 574-90.","DOI":"10.1111\/j.1476-5381.2011.01395.x"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Menzaghi C, Trischitta V. The adiponectin paradox for all-cause and cardiovascular mortality. Diabetes 2018; 67: 12-22.","DOI":"10.2337\/dbi17-0016"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Ogunwobi OO, Beales IL. Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul Pept 2006; 134: 105-13.","DOI":"10.1016\/j.regpep.2006.02.001"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Fayad R, Pini M, Sennello JA, <i>et al<\/i>. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 2007; 132: 601-14.","DOI":"10.1053\/j.gastro.2006.11.026"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Liu D, Luo S, Li Z. Multifaceted roles of adiponectin in rheumatoid arthritis. Int Immunopharmacol 2015; 28: 1084-90.","DOI":"10.1016\/j.intimp.2015.08.013"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Tang WH, Shrestha K, Tong W, <i>et al<\/i>. Nitric oxide bioavailability and adiponectin production in chronic systolic heart failure: relation to severity of cardiac dysfunction. Transl Res 2013; 162: 26-33.","DOI":"10.1016\/j.trsl.2013.02.005"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Hoyda TD, Ferguson AV. Adiponectin modulates excitability of rat paraventricular nucleus neurons by differential modulation of potassium currents. Endocrinology 2010; 151: 3154-62.","DOI":"10.1210\/en.2009-1390"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Matsumoto T, Ohnishi H, Sato T, <i>et al<\/i>. Insulin resistance is associated with longitudinal changes of cardiac repolarization heterogeneity in apparently healthy subjects. Cardiol Ther 2019, in press.","DOI":"10.1007\/s40119-019-0140-7"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Bidulescu A, Liu J, Musani SK, <i>et al<\/i>. Association of adiponectin with left ventricular mass in blacks: the Jackson heart study. Circ Heart Fail 2011; 4: 747-53.","DOI":"10.1161\/CIRCHEARTFAILURE.110.959742"},{"key":"42","unstructured":"42. Ayerden Ebinc F, Ebinc H, Derici U, <i>et al<\/i>. The relationship between adiponectin levels and proinflammatory cytokines and left ventricular mass in dialysis patients. J Nephrol 2009; 22: 216-23."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Komaba H, Igaki N, Goto S, <i>et al<\/i>. Adiponectin is associated with brain natriuretic peptide and left ventricular hypertrophy in hemodialysis patients with type 2 diabetes mellitus. Nephron Clin Pract 2007; 107: c103-8.","DOI":"10.1159\/000108651"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44. Kistorp C, Faber J, Galatius S, <i>et al<\/i>. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005; 112: 1756-62.","DOI":"10.1161\/CIRCULATIONAHA.104.530972"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Tamura T, Furukawa Y, Taniguchi R, <i>et al<\/i>. Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. Circ J 2007; 71: 623-30.","DOI":"10.1253\/circj.71.623"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Shinmura K. Is adiponectin a bystander or a mediator in heart failure? The tangled thread of a good-natured adipokine in aging and cardiovascular disease. Heart Fail Rev 2010; 15: 457-66.","DOI":"10.1007\/s10741-010-9159-5"},{"key":"47","unstructured":"47. Barnett AS, Piccini JP. Adiponectin: an accurate biomarker for patients at risk for atrial fibrillation? Heart 2015; 101: 1351-2."},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Wang Y, Ma XL, Lau WB. Cardiovascular adiponectin resistance: the critical role of adiponectin receptor modification. Trends Endocrinol Metab 2017; 28: 519-30.","DOI":"10.1016\/j.tem.2017.03.004"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Wang TJ, Larson MG, Levy D, <i>et al<\/i>. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655-63.","DOI":"10.1056\/NEJMoa031994"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Del Gobbo LC, Imamura F, Wu JH, de Oliveira Otto MC, Chiuve SE, Mozaffarian D. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr 2013; 98: 160-73.","DOI":"10.3945\/ajcn.112.053132"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Adamopoulos C, Pitt B, Sui X, Love TE, Zannad F, Ahmed A. Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched study. Int J Cardiol 2009; 136: 270-7.","DOI":"10.1016\/j.ijcard.2008.05.006"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/1\/61_19-270\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T03:47:06Z","timestamp":1580528826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/1\/61_19-270\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.19-270","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]}}}